Effect of Pioglitazone on Pancreatic Steatosis and Bone Health.

Trial Profile

Effect of Pioglitazone on Pancreatic Steatosis and Bone Health.

Completed
Phase of Trial: Phase III

Latest Information Update: 15 Dec 2017

At a glance

  • Drugs Pioglitazone (Primary)
  • Indications Insulin resistance
  • Focus Biomarker; Pharmacodynamics
  • Most Recent Events

    • 27 Sep 2013 Results presented at the 49th Annual Meeting of the European Association for the Study of Diabetes.
    • 24 Oct 2012 Status changed from recruiting to completed.
    • 05 Oct 2012 Results presented at the 48th Annual Meeting of the European Association for the Study of Diabetes.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top